About the Product

Description


Canditen 8 Tablet containing Candesartan is used for the management of hypertension and cardiac conditions. It helps in lowering blood pressure and improving cardiovascular health.

Candesartan works as an angiotensin receptor blocker (ARB) that relaxes blood vessels, improves blood flow, and reduces strain on the heart.

The tablet is widely prescribed in cardiology and general medicine practice for long-term blood pressure management, leading to consistent demand and repeat usage.

With increasing prevalence of hypertension and cardiovascular disorders, this product offers strong business potential for retailers and distributors. Its chronic therapy requirement, steady prescription demand, and broad clinical acceptance make it a reliable product for consistent sales and growth in the cardiac segment.

Some patients may experience dizziness, headache, fatigue, low blood pressure, or increased potassium levels. Rarely, kidney function changes or allergic reactions may occur and require medical attention.

Canditen 8 Tablet is indicated for the treatment of hypertension and heart failure. It helps lower blood pressure, reduce strain on the heart, improve cardiovascular function, and decrease the risk of heart-related complications.

This medicine should be used under medical supervision. Regular monitoring of blood pressure, kidney function, and electrolyte levels is recommended. Use cautiously in patients with kidney disorders or dehydration.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Canditen 8 Tablet in the PCD pharma franchise market?

Canditen 8 Tablet, containing Candesartan 8mg, has strong demand in the cardiology and hypertension segment, making it a high-volume product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiovascular and chronic care portfolios.

Why should medical distributors include Canditen 8 Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for angiotensin receptor blockers (ARBs) used in hypertension, heart failure, and renal protection in diabetic patients. Canditen 8 Tablet helps strengthen a comprehensive cardiology and kidney-care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Canditen 8 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Canditen 8 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Canditen 8 Tablet distribution?

Wholesalers and medical agencies benefit from stable long-term prescription demand, reliable supply chain support, good margins, and professional assistance when partnering for Canditen 8 Tablet distribution.

How can I become a distributor or franchise partner for Canditen 8 Tablet?

Medical distributors, stockists, and wholesalers interested in Canditen 8 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.